Variable histological and ultrasonic characteristics of restenosis after drug-eluting stents

International Journal of Cardiology

Volumn 130, Issue 3, 2008, Pages 444-448

  Suzuki, Nobuaki ^a   Angiolillo, Dominick J ^b   Monteiro, Carmela ^b   Shuja, Sania ^b   Futamatsu, Hideki ^b   Kawaguchi, Ren ^b   Box, Lyndon C ^b   Guzman, Luis ^b   Zenni, Martin M ^b   Gilmore, Paul S ^b   Bass, Theodore A ^b   Costa, Marco A ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Atherectomy; Drug eluting stent; Intravascular ultrasound; Pathology; Percutaneous coronary intervention

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; RAPAMYCIN;

ADULT; AGED; ARTICLE; ATHERECTOMY; CATHETER; CELL INFILTRATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG ELUTING STENT; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRAVASCULAR ULTRASOUND; MACROPHAGE; MALE; PRIORITY JOURNAL; RESTENOSIS; SMOOTH MUSCLE FIBER; STABLE ANGINA PECTORIS; T LYMPHOCYTE; THROMBECTOMY;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ATHERECTOMY; CORONARY DISEASE; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; FEMALE; FIBRIN; HUMANS; MACROPHAGES; MALE; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; T-LYMPHOCYTES; THROMBECTOMY; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 55549097115     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2007.08.143     Document Type: Article

References (23)

1. Morice M.C., Serruys P.W., Sousa J.E., et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346 23 (2002) 1773-1780
2. Stone G.W., Ellis S.G., Cox D.A., et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 350 3 (2004) 221-231
3. Lemos P.A., Serruys P.W., van Domburg R.T., et al. Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the "real world": the rapamycin-eluting stent evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry. Circulation 109 2 (2004) 190-195
4. Sousa J.E., Costa M.A., Abizaid A., et al. Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation 103 2 (2001) 192-195
5. Joner M., Finn A.V., Farb A., et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 48 1 (2006) 193-202
6. Shuchman M. Trading restenosis for thrombosis? New questions about drug-eluting stents. N Engl J Med 355 19 (2006) 1949-1952
7. Virmani R., Guagliumi G., Farb A., et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious?. Circulation 109 6 (2004) 701-705
8. Chen M.S., John J.M., Chew D.P., Lee D.S., Ellis S.G., and Bhatt D.L. Bare metal stent restenosis is not a benign clinical entity. Am Heart J 151 6 (2006) 1260-1264
9. Angiolillo D., and Alfonso F. Intravascular ultrasound. In: Kay P., Sabate M., and Costa M. (Eds). Cardiac catheterization and percutaneous interventions (2004), Taylor & Francis, London 259-284
10. Komatsu R., Ueda M., Naruko T., Kojima A., and Becker A.E. Neointimal tissue response at sites of coronary stenting in humans: macroscopic, histological, and immunohistochemical analyses. Circulation 98 3 (1998) 224-233
11. Moreno P.R., Palacios I.F., Leon M.N., Rhodes J., Fuster V., and Fallon J.T. Histopathologic comparison of human coronary in-stent and post-balloon angioplasty restenotic tissue. Am J Cardiol 84 4 (1999) 462-466 [A9]
12. Farb A., Sangiorgi G., Carter A.J., et al. Pathology of acute and chronic coronary stenting in humans. Circulation 99 1 (1999) 44-52
13. Welt F.G., and Rogers C. Inflammation and restenosis in the stent era. Arterioscler Thromb Vasc Biol 22 11 (2002) 1769-1776
14. Costa M.A., and Simon D.I. Molecular basis of restenosis and drug-eluting stents. Circulation 111 17 (2005) 2257-2273
15. Drachman D.E., Edelman E.R., Seifert P., et al. Neointimal thickening after stent delivery of paclitaxel: change in composition and arrest of growth over six months. J Am Coll Cardiol 36 7 (2000) 2325-2332
16. Farb A., Heller P.F., Shroff S., et al. Pathological analysis of local delivery of paclitaxel via a polymer-coated stent. Circulation 104 4 (2001) 473-479
17. Suzuki T., Kopia G., Hayashi S., et al. Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model. Circulation 104 10 (2001) 1188-1193
18. Finn A.V., Kolodgie F.D., Harnek J., et al. Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents. Circulation 112 2 (2005) 270-278
19. Kotani J., Awata M., Nanto S., et al. Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings. J Am Coll Cardiol 47 10 (2006) 2108-2111
20. Takano M., Ohba T., Inami S., Seimiya K., Sakai S., and Mizuno K. Angioscopic differences in neointimal coverage and in persistence of thrombus between sirolimus-eluting stents and bare metal stents after a 6-month implantation. Eur Heart J 27 18 (2006) 2189-2195
21. Kay I.P., Wardeh A.J., Kozuma K., et al. The pattern of restenosis and vascular remodelling after cold-end radioactive stent implantation. Eur Heart J 22 15 (2001) 1311-1317
22. Costa M.A., Sabate M., Angiolillo D.J., et al. Intravascular ultrasound characterization of the "black hole" phenomenon after drug-eluting stent implantation. Am J Cardiol 97 2 (2006) 203-206
23. Serrano P., Kross J.M., Ligthart J.M., Costa M.A., Sabate M., and de Feyter P.J. Diagnosis of an intracoronary thrombus with intravascular ultrasound. Circulation 101 8 (2000) E84-E85